Identification and characterization of the Rhizobium sp. Strain GIN611 glycoside oxidoreductase resulting in the deglycosylation of ginsenosides

Applied and Environmental Microbiology

Volumn 78, Issue 1, 2012, Pages 242-249

  Kim, Eun Mi ^a   Kim, Juhan ^b   Seo, Joo Hyun ^a   Park, Jun Seong ^c   Kim, Duck Hee ^c   Kim, Byung Gee ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF COLORADO   (United States)

^c AmorePacific Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CO-EXPRESSION; CODING SEQUENCES; COMPOUND K; DAIDZIN; DEGLYCOSYLATION; ENRICHMENT CULTURE; GINSENOSIDES; HETERODIMERIC PROTEINS; ISOFLAVONES; OXIDATION ACTIVITIES; OXIDOREDUCTASES; PHOSPHATE BUFFERS; RECOMBINANT ESCHERICHIA COLI; RHIZOBIUM SP; SMALL SUBUNITS; SOLUBLE EXPRESSION;

ESCHERICHIA COLI; GLUCOSE; OXIDATION; PHARMACODYNAMICS; PURIFICATION;

GLYCOSIDES;

BACTERIAL DNA; GINSENOSIDE; OXIDOREDUCTASE; PLANT EXTRACT; PROTOPANAXADIOL; RECOMBINANT PROTEIN; SAPOGENIN;

COLIFORM BACTERIUM; ENZYME ACTIVITY; GENOME; GLUCOSE; OXIDATION; PHOSPHATE; PROTEIN; RHIZOBACTERIUM;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PANAX; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; RHIZOBIUM;

BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA, BACTERIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GINSENOSIDES; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; OXIDOREDUCTASES; PANAX; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RHIZOBIUM; SAPOGENINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ESCHERICHIA COLI; RHIZOBIUM SP.;

EID: 84862946215     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.06404-11     Document Type: Article

References (41)

1. Andreea Neculai M, Ivanov D, Bernards MA. 2009. Partial purification and characterization of three ginsenoside-metabolizing beta-glucosidases from Pythium irregulare. Phytochemistry 70:1948-1957.
2. Bae EA, Han MJ, Choo MK, Park SY, Kim DH. 2002. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull. 25:58-63.
3. Bae EA, Shin JE, Kim DH. 2005. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect. Biol. Pharm. Bull. 28: 1903-1908.
4. Bessette PH, Aslund F, Beckwith J, Georgiou G. 1999. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc. Natl. Acad. Sci. U. S. A. 96:13703-13708.
5. Cameron RG, Manthey JA, Baker RA, Grohmann K. 2001. Purification and characterization of a beta-glucosidase from Citrus sinensis var. Valencia fruit tissue. J. Agric. Food Chem. 49:4457-4462.
6. Chen CF, Chiou WF, Zhang JT. 2008. Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacol. Sin. 29:1103-1108.
7. Chen GT, et al. 2008. Microbial transformation of ginsenoside Rb(1) by Acremonium strictum. Appl. Microbiol. Biotechnol. 77:1345-1350.
8. Cheng LQ, Na JR, Bang MH, Kim MK, Yang DC. 2008. Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by Microbacterium sp. GS514. Phytochemistry 69:218-224.
9. Chi H, Kim DH, Ji GE. 2005. Transformation of ginsenosides Rb2 and Rc from Panax ginseng by food microorganisms. Biol. Pharm. Bull. 28: 2102-2105.
10. Choi K, Choi C. 2009. Proapoptotic ginsenosides compound K and Rh enhance Fas-induced cell death of human astrocytoma cells through distinct apoptotic signaling pathways. Cancer Res. Treat. 41:36-44.
11. Gatlin CL, Kleemann GR, Hays LG, Link AJ, Yates JR III. 1998. Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry. Anal. Biochem. 263:93-101.
12. Han BH, et al. 1982. Degradation of ginseng saponins under mild acidic conditions. Planta Med. 44:146-149.
13. Han Y, et al. 2007. Transformation of bioactive compounds by Fusarium sacchari fungus isolated from the soil-cultivated ginseng. J. Agric. Food Chem. 55:9373-9379.
14. Hasegawa H. 2004. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J. Pharmacol. Sci. 95: 153-157.
15. Hasegawa H, Sung JH, Benno Y. 1997. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med. 63:436-440.
16. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. 1996. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 62: 453-457.
17. Kim DH, et al. 2003. Inhibition of intracerebroventricular injection stress-induced plasma corticosterone levels by intracerebroventricularly administered compound K, a ginseng saponin metabolite, in mice. Biol. Pharm. Bull. 26:1035-1038.
18. Kim DY, et al. 2009. Compound K induces apoptosis via CAMK-IV/ AMPK pathways in HT-29 colon cancer cells. J. Agric. Food Chem. 57: 10573-10578.
19. Kim MK, Lee JW, Lee KY, Yang DC. 2005. Microbial conversion of major ginsenoside rb(1) to pharmaceutically active minor ginsenoside rd. J. Microbiol. 43:456-462.
20. Kim S, et al. 2004. Compound K induces expression of hyaluronan synthase 2 gene in transformed human keratinocytes and increases hyaluronan in hairless mouse skin. Biochem. Biophys. Res. Commun. 316: 348-355.
21. Kitagawa S, Takahashi T, Nabekura T, Tachikawa E, Hasegawa H. 2007. Inhibitory effects of ginsenosides and their hydrolyzed metabolites on daunorubicin transport in KB-C2 cells. Biol. Pharm. Bull. 30:1979-1981.
22. Ko SR, Choi KJ, Suzuki K, Suzuki Y. 2003. Enzymatic preparation of ginsenosides Rg2, Rh1, and F1. Chem. Pharm. Bull. (Tokyo) 51:404-408.
23. Ko SR, Suzuki Y, Suzuki K, Choi KJ, Cho BG. 2007. Marked production of ginsenosides Rd, F2, Rg3, and compound K by enzymatic method. Chem. Pharm. Bull. (Tokyo) 55:1522-1527.
24. Lee JH, et al. 2008. Improving the growth rate of Escherichia coli DH5alpha at low temperature through engineering of GroEL/S chaperone system. Biotechnol. Bioeng. 99:515-520.
25. Lewis JA, Escalante-Semerena JC. 2006. The FAD-dependent tricarballylate dehydrogenase (TcuA) enzyme of Salmonella enterica converts tricarballylate into cis-aconitate. J. Bacteriol. 188:5479-5486.
26. Liu TG, et al. 2009. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 9:250.
27. Marchler-Bauer A, et al. 2009. CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Res. 37:D205-D210.
28. Ota T, Maeda M, Odashima S. 1991. Mechanism of action of ginsenoside Rh2: uptake and metabolism of ginsenoside Rh2 by cultured B16 melanoma cells. J. Pharm. Sci. 80:1141-1146.
29. Park SY, Bae EA, Sung JH, Lee SK, Kim DH. 2001. Purification and characterization of ginsenoside Rb1-metabolizing beta-glucosidase from Fusobacterium K-60, a human intestinal anaerobic bacterium. Biosci. Biotechnol. Biochem. 65:1163-1169.
30. Rye CS, Withers SG. 2000. Glycosidase mechanisms. Curr. Opin. Chem. Biol. 4:573-580.
31. Shibata S. 2001. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J. Korean Med. Sci. 16(Suppl):S28-S37.
32. Shin HY, Park SY, Sung JH, Kim DH. 2003. Purification and characterization of alpha-L-arabinopyranosidase and alpha-L-arabinofuranosidase from Bifidobacterium breve K-110, a human intestinal anaerobic bacterium metabolizing ginsenoside Rb2 and Rc. Appl. Environ. Microbiol. 69:7116-7123.
33. Son JW, Kim HJ, Oh DK. 2008. Ginsenoside Rd production from the major ginsenoside Rb(1) by beta-glucosidase from Thermus caldophilus. Biotechnol. Lett. 30:713-716.
34. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. 2003. Degradation of ginsenosides in humans after oral administration. Drug Metab. Dispos. 31:1065-1071.
35. Wang W, et al. 2007. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother. Pharmacol. 59:589-601.
36. Wierenga RK, Terpstra P, Hol WG. 1986. Prediction of the occurrence of the ADP-binding beta alpha beta-fold in proteins, using an amino acid sequence fingerprint. J. Mol. Biol. 187:101-107.
37. Yan Q, et al. 2008. Purification and properties of a novel beta-glucosidase, hydrolyzing ginsenoside Rb1 to CK, from Paecilomyces bainier. J. Microbiol. Biotechnol. 18:1081-1089.
38. Ye L, et al. 2011. Biotransformation of ginsenoside Rb1 to ginsenoside Rd by highly substrate-tolerant Paecilomyces bainier 229-7. Bioresour. Technol. 101:7872-7876.
39. Yim JS, et al. 2004. Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. Biol. Pharm. Bull. 27:1580-1583.
40. Yu H, et al. 2007. Purification and characterization of new special ginsenosidase hydrolyzing multi-glycisides of protopanaxadiol ginsenosides, ginsenosidase type I. Chem. Pharm. Bull. (Tokyo) 55:231-235.
41. Zhang C, Yu H, Bao Y, An L, Jin F. 2001. Purification and characterization of ginsenoside-beta-glucosidase from ginseng. Chem. Pharm. Bull. (Tokyo) 11. 49:795-798.